Table 1.

The level of serum lipid, ERRα and TFEB in tissue microarray of EC patients and controls

Parameter (N=111)	TG	p	CHOL	p	HDL	p	APO-A	p	LDL	p	APO-B	p	TFEB				ERRα
													-/+	++	+++	p	-/+	++	+++	p
Normal (n=32)	1.027±0.882	0.032	4.623±0.853	0.649	1.599±0.412	0.041	1.331±0.229	0.026	2.709±0.830	0.568	0.834±0.229	0.157	24	8	0	<0.001	27	5	0	<0.001
EC (n=79)	1.549±1.369		4.723±1.032		1.394±0.428		1.207±0.226		2.578±0.929		0.924±0.338		26	38	15		14	55	10
Stage I-II (n=62)	1.556±1.538	0.859	4.703±1.133	0.192	1.388±0.470	0.980	1.191±0.224	0.691	2.693±0.985	0.178	0.935±0.381	0.785	19	31	12	0.710	13	41	8	0.328
Stage III-IV (n=17)	1.622±1.019		5.055±0.719		1.386±0.234		1.218±0.210		3.148±0.636		0.958±0.236		7	7	3		1	14	2
MI <50% (n=55)	1.597±1.531	0.589	4.742±1.064	0.806	1.388±0.463	0.827	1.196±0.219	0.550	2.593±0.979	0.880	0.936±0.362	0.618	21	29	5	0.003	14	35	6	0.024
MI ≥50% (n=24)	1.445±0.933		4.680±0.979		1.408±0.350		1.231±0.244		2.553±0.869		0.898±0.282		5	9	10		0	20	4
EEC (n=63)	1.515±1.397	0.592	4.790±1.056	0.184	1.424±0.452	0.120	1.218±0.225	0.390	2.706±0.976	0.021	0.950±0.353	0.100	20	32	11	0.613	13	41	9	0.216
NEEC (n=16)	1.711±1.256		4.412±0.887		1.274±0.301		1.162±0.232		2.133±0.578		0.819±0.254		6	6	4		1	14	1
LNM (n=9)	1.605±1.447	0.316	4.724±1.059	0.729	1.367±0.421	0.046	1.193±0.223	0.151	2.640±0.946	0.092	0.925±0.351	0.984	5	2	2	0.232	1	7	1	0.842
No-LNM (n=70)	1.413±0.380		4.836±0.812		1.637±0.439		1.326±0.242		1.980±0.666		0.923±0.253		21	36	13		13	48	9

Abbreviations: APO-A Apolipoprotein A, APO-B Apolipoprotein B, CHOL Cholesterol, ERRα Estrogen-Related Receptor α, EC Endometrial Cancer, EEC Endometrioid Endometrial Cancer, HDL High-Density Lipoprotein, LDL Low-Density Lipoprotein, LNM Lymph Node Metastasis, MI Myometrial Invasion, NEEC Non-Endometrioid Endometrial Cancer, TG total Triglyceride, TFEB Transcription Factor EB. p < 0.05 suggests significantly different